Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates
about
Computational approaches for evaluating the effect of sequence variations and the intrinsically disordered C-terminal region of the Helicobacter pylori CagA protein on the interaction with tyrosine kinase Src.Application of PCR amplicon sequencing using a single primer pair in PCR amplification to assess variations in Helicobacter pylori CagA EPIYA tyrosine phosphorylation motifs.Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population.CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis.High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, SpainAssociation between cagA and vacA genotypes and pathogenesis in a Helicobacter pylori infected population from South-eastern Sweden.CagA phosphorylation EPIYA-C motifs and the vacA i genotype in Helicobacter pylori strains of asymptomatic children from a high-risk gastric cancer area in northeastern BrazilSystematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains.c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strainsSystematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strainsIn vitro effect of amoxicillin and clarithromycin on the 3' region of cagA gene in Helicobacter pylori isolatesCagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children.Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotypingRapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH.Effect of treatment failure on the CagA EPIYA motif in Helicobacter pylori strains from Colombian subjects.A mutagenesis method for the addition and deletion of highly repetitive DNA regions: the paradigm of EPIYA motifs in the cagA gene of Helicobacter pylori.Isolation and characterization of Helicobacter pylori recovered from gastric biopsies under anaerobic conditions.Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center.
P2860
Q30365619-B93505CE-F951-44B0-8EC3-585F865FF2AEQ33533972-43B3183D-B6D5-413C-A586-3B59F0880506Q33637846-E61B8FDF-35DA-443D-8C57-38E6EDB218FDQ33909465-0192FE73-46A4-4923-9619-A30D2C6FC225Q34073621-F50146DC-4AF5-4B0D-9C27-040B03AC4530Q34190303-5979213C-26E2-4910-A24D-84DF21809181Q34322144-0FE82801-FD5D-420E-B0B9-1440B135DFB2Q35076414-530035C4-ECEC-4F85-9FA4-48C68FCD5020Q35163573-E82D9AFF-2F7B-4400-8EEE-5BFEAE1D60D4Q35858125-C3512DF4-A5B6-4993-BF80-E75BF174037CQ36121958-3833BAB9-74ED-470D-ABAC-55D4ACED505DQ37203555-77B89712-4CD6-451E-B5B8-8EA371CABBB9Q37302167-CBA6162C-2E9F-4B35-B6BE-F71671B46303Q37410049-2D4751B9-CAAF-4CEA-A271-935F0F0FFBA3Q37601719-22E7C432-6AB1-4152-A400-3C6B979888ADQ37714349-1418BECD-5A2F-4998-8AE4-2B073DF7790DQ39236598-4F81DADD-2AD7-4569-93C7-169ACD3F5827Q40601723-80784DB1-BA80-4667-AFC5-B894D366FCCFQ54267284-09F0D875-30C4-470F-A1D4-5A05658BCDF3
P2860
Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Strategy to characterize the n ...... acter pylori clinical isolates
@ast
Strategy to characterize the n ...... acter pylori clinical isolates
@en
type
label
Strategy to characterize the n ...... acter pylori clinical isolates
@ast
Strategy to characterize the n ...... acter pylori clinical isolates
@en
prefLabel
Strategy to characterize the n ...... acter pylori clinical isolates
@ast
Strategy to characterize the n ...... acter pylori clinical isolates
@en
P2093
P2860
P356
P1476
Strategy to characterize the n ...... acter pylori clinical isolates
@en
P2093
Andreas F Mentis
Antonios Kalliaropoulos
Athanasios J Archimandritis
Dionyssios N Sgouras
Effrosini G Panayotopoulou
George Papatheodoridis
Konstantinos Papadakos
P2860
P304
P356
10.1128/JCM.01616-06
P407
P577
2006-12-06T00:00:00Z